Nomenclature
CAS number: 57-83-0
Pregn-4-ene-3,20-dione; Δ
4-pregnene-3,20-dione; corpus luteum hormone; luteohormone; Crinone (Serono); Cyclogest (Alpharma); Estima (EFFIK); Gestone (Nordic); Menaelle (Théramex); Progestasert (Alza); Progestogel (Besins-Iscovesco); Progeston (Fuji); Proluton (Schering AG); Utrogestan (Besins-Iscovesco).
C
21H
30O
2; mol wt 314.46.
C 80.21%, H 9.62%, O 10.18%.
Description and references
Active principle of the corpus luteum, secreted
during the latter half of the menstrual cycle. If pregnancy ensues,
secretion continues. Exerts an antiovulatory effect when administered
during days 5 to 25 of the normal menstrual cycle. Isoln from corpus
luteum of pregnant sows: Butenandt, Westphal, Ber. 67, 1440 (1934); Wintersteiner, Allen, J. Biol. Chem. 107, 321 (1934).
Structure: Butenandt et al., Ber. 67, 1611 (1934). Synthesis of dl-form: Johnson et al., J. Am.
Chem. Soc. 93, 4332 (1971). Prepn from other
steroids in review by W. H. Strain in Gilman's Organic Chemistry vol. II (Wiley, New York,
2nd ed., 1943) pp 1487-1489. Numerous patents, e.g., US 2379832; US 2232438; US 2314185. Anesthetic
effect and toxicity: H. Selye, Proc. Soc.
Exp. Biol. Med. 46, 116 (1941). Review of
physiology: Csapo, Sci. Am. 198, 40-46 (April, 1958); Rothchild, Vitam. Horm. 23, 209-327 (1965). Book: Progesterone and Progestins, C. W. Bardin et al., Eds. (Raven Press, New York, 1982) 462 pp.
Properties
Exists in two cryst forms of equal physiologic
activity and which are readily interconverted. The α-form is orthorhombic
(prisms from dil alc) with a:b:c = 0.750:1:0.905. Crystals show (011),
(110), (010). Poor (011) cleavage. d23 1.166. mp 127-131°. The β-form is orthorhombic (needles)
with a:b:c = 0.563:1:0.275. Crystals acicular with parallel extinction
and negative elongation. Cleavage on (001) and (110). d20 1.171. mp 121°. [α]D20 +172 to +182° (c
= 2 in dioxane). uv max: 240 nm. Insol in water. Sol in alcohol,
acetone, dioxane, concd H2SO4. Sparingly sol
in vegetable oils. 1 mg = 1 I.U.Caution
This substance is reasonably anticipated
to be a human carcinogen: Report on Carcinogens,
Eleventh Edition (PB2005-104914, 2004) p III-223.Therapeutic Category
Progestogen.
Therapeutic Category (Veterinary)
Progestogen. Has been used to control
habitual abortion, to suppress or synchronize estrus.
Keywords
Progestogen